HIV

HIV

The acquired immunodeficiency syndrome (AIDS), a condition in which the immune system gradually fails and life-threatening opportunistic infections and cancers proliferate, is brought on by the lentivirus (a subgroup of retrovirus) known as HIV. HIV infection happens when blood, semen, vaginal fluid, pre-ejaculate, or breast milk are shared. HIV can be found in these bodily fluids as both free virus particles and as a virus inside infected immune cells.Important immune system components like helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells are all infected by HIV. Apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells are some of the mechanisms by which HIV infection results in low levels of CD4+ T cells. Cell-mediated immunity is lost and the body becomes progressively more vulnerable to opportunistic infections when CD4+ T cell counts fall below a critical threshold.

HIV related products

Structure Cat No. Product Name CAS No. Product Description
V54264 Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium 2611373-74-9 Tenofovir-C3-O-C12-trimethylsilylacetylene (ammonium) displays longer t1/2 values than tenofovir in human liver microsomes, has potent anti-HIV activity in vitro, and enhances pharmacokinetic properties in vivo.
V54269 Tenofovir-C3-O-C15-CF3 ammonium 2611373-80-7 Tenofovir-C3-O-C15-CF3 (ammonium) displays longer t1/2 values than tenofovir in human liver microsomes, has potent anti-HIV activity in vitro, and enhances pharmacokinetic properties in vivo.
V54247 Teropavimab (3BNC117-LS; GS-5423) 2417213-72-8 Teropavimab (3BNC117-LS) is an antibody.
V54253 Tifuvirtide (T-1249) 251562-00-2 Tifuvirtide (T-1249) is a bioactive peptide human immunodeficiency virus type 1 (HIV-1) fusion inhibitor.
V35196 Tigloylgomisin P (crotonylgomisin P) 69176-51-8 Tigloylgomisin P is a lignin with anti-HIV (Human Immunodeficiency Virus) activity with EC50 of 37 μM.
V50921 TN-14003 368874-31-1 anti-HIV peptide
V53221 Trecovirsen (GEM91) 153021-75-1 Trecovirsen (GEM91) is an antisense oligonucleotide targeting the HIV gag gene.
V52922 Trovirdine (Travirdine; LY300046) 149488-17-5 Trovirdine inhibits HIV-1 reverse transcription with IC50 of 7 nM.
V54284 Tsugafolin 66568-97-6 Tsugafolin (compound 4) is a dehydroflavone with weak anti-HIV activity (IC50=118 μM) and no cytotoxic effect (<150 μM).
V81736 VIR-165 VIR-165 is a modified form of a viral inhibitory peptide (VIRIP) that binds to a fusion peptide of the gp41 subunit and prevents its entry into target membranes.
V54243 Wilfortrine (triptolide) 37239-48-8 Wilfortrine is a bioactive sesquiterpene alkaloid.
V54267 Zinlirvimab (10-1074) 2417213-75-1 Zinlirvimab is a humanized IgG1-λ2 HIV neutralizing antibody that targets the HIV-1 gp120 envelope glycoprotein (IIIB gp120 V3 loop).
V76070 β-Rubromycin 27267-70-5 β-Rubromycin is a potent and specific inhibitor of human immunodeficiency virus-1 (HIV-1) RNA-directed DNA polymerase (reverse transcriptase).
Contact Us Back to top